<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1993-07-01" modified="2017-09-27" version="164">
<accession>P31213</accession>
<accession>B2RE87</accession>
<accession>Q2M1R4</accession>
<accession>Q9BYE6</accession>
<name>S5A2_HUMAN</name>
<protein>
<recommendedName>
<fullName>3-oxo-5-alpha-steroid 4-dehydrogenase 2</fullName>
<ecNumber evidence="4">1.3.1.22</ecNumber>
</recommendedName>
<alternativeName>
<fullName>5 alpha-SR2</fullName>
</alternativeName>
<alternativeName>
<fullName>SR type 2</fullName>
</alternativeName>
<alternativeName>
<fullName>Steroid 5-alpha-reductase 2</fullName>
<shortName>S5AR 2</shortName>
</alternativeName>
<alternativeName>
<fullName>Type II 5-alpha reductase</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">SRD5A2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1991" name="Nature" volume="354" first="159" last="161">
<title>Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism.</title>
<authorList>
<person name="Andersson S."/>
<person name="Berman D.M."/>
<person name="Jenkins E.P."/>
<person name="Russell D.W."/>
</authorList>
<dbReference type="PubMed" id="1944596"/>
<dbReference type="DOI" id="10.1038/354159a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1992" name="Endocrinology" volume="131" first="1571" last="1573">
<title>Structure of human type II 5 alpha-reductase gene.</title>
<authorList>
<person name="Labrie F."/>
<person name="Sugimoto Y."/>
<person name="Luu-The V."/>
<person name="Simard J."/>
<person name="Lachance Y."/>
<person name="Bachvarov D."/>
<person name="Leblanc G."/>
<person name="Durocher F."/>
<person name="Paquet N."/>
</authorList>
<dbReference type="PubMed" id="1505484"/>
<dbReference type="DOI" id="10.1210/endo.131.3.1505484"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="submission" date="2007-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Schupp I."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT LEU-89</scope>
<source>
<tissue>Liver tumor</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="2005-01" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS THR-49; LEU-89 AND VAL-113</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT LEU-89</scope>
</reference>
<reference key="8">
<citation type="submission" date="2000-08" db="EMBL/GenBank/DDBJ databases">
<title>Transcription of type II 5 alpha-reductase is up-regulated by SRY in human dermal papilla cells.</title>
<authorList>
<person name="Nakanishi J."/>
<person name="Hibino T."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-67</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1992" name="J. Clin. Invest." volume="90" first="799" last="809">
<title>Molecular genetics of steroid 5 alpha-reductase 2 deficiency.</title>
<authorList>
<person name="Thigpen A.E."/>
<person name="Davis D.L."/>
<person name="Milatovich A."/>
<person name="Mendonca B.B."/>
<person name="Imperato-Mcginley J."/>
<person name="Griffin J.E."/>
<person name="Francke U."/>
<person name="Wilson J.D."/>
<person name="Russell D.W."/>
</authorList>
<dbReference type="PubMed" id="1522235"/>
<dbReference type="DOI" id="10.1172/JCI115954"/>
</citation>
<scope>VARIANT PPSH TRP-246</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1995" name="Clin. Endocrinol. (Oxf.)" volume="43" first="183" last="188">
<title>A new deletion of the 5-alpha-reductase type 2 gene in a Turkish family with 5-alpha-reductase deficiency.</title>
<authorList>
<person name="Boudon C."/>
<person name="Lobaccaro J.-M."/>
<person name="Lumbroso S."/>
<person name="Ogur G."/>
<person name="Ocal G."/>
<person name="Belon C."/>
<person name="Sultan C."/>
</authorList>
<dbReference type="PubMed" id="7554313"/>
<dbReference type="DOI" id="10.1111/j.1365-2265.1995.tb01913.x"/>
</citation>
<scope>VARIANT PPSH MET-157 DEL</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1996" name="J. Clin. Endocrinol. Metab." volume="81" first="1730" last="1735">
<title>5-alpha-reductase-2 gene mutations in the Dominican Republic.</title>
<authorList>
<person name="Cai L.-Q."/>
<person name="Zhu Y.-S."/>
<person name="Katz M.D."/>
<person name="Herrera C."/>
<person name="Baez J."/>
<person name="DeFillo-Ricart M."/>
<person name="Shackleton C.H.L."/>
<person name="Imperato-McGinley J."/>
</authorList>
<dbReference type="PubMed" id="8626825"/>
<dbReference type="DOI" id="10.1210/jcem.81.5.8626825"/>
</citation>
<scope>VARIANTS PPSH ASP-115; SER-183 AND TRP-246</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1996" name="J. Clin. Endocrinol. Metab." volume="81" first="2821" last="2827">
<title>Clinical, biochemical, and genetic findings in a large pedigree of male and female patients with 5-alpha-reductase 2 deficiency.</title>
<authorList>
<person name="Hochberg Z."/>
<person name="Chayen R."/>
<person name="Reiss N."/>
<person name="Falik Z."/>
<person name="Makler A."/>
<person name="Munichor M."/>
<person name="Farkas A."/>
<person name="Goldfarb H."/>
<person name="Ohana N."/>
<person name="Hiort O."/>
</authorList>
<dbReference type="PubMed" id="8768837"/>
<dbReference type="DOI" id="10.1210/jcem.81.8.8768837"/>
</citation>
<scope>VARIANT PPSH GLN-55</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1997" name="Mol. Pathol." volume="50" first="51" last="52">
<title>Male pseudohermaphroditism resulting from a novel mutation in the human steroid 5 alpha-reductase type 2 gene (SRD5A2).</title>
<authorList>
<person name="Anwar R."/>
<person name="Gilbey S.G."/>
<person name="New J.P."/>
<person name="Markham A.F."/>
</authorList>
<dbReference type="PubMed" id="9208814"/>
<dbReference type="DOI" id="10.1136/mp.50.1.51"/>
</citation>
<scope>VARIANT PPSH LYS-200</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1998" name="Am. J. Med. Genet." volume="80" first="269" last="272">
<title>Homozygous mutation (A228T) in the 5-alpha-reductase type 2 gene in a boy with 5-alpha-reductase deficiency: genotype-phenotype correlations.</title>
<authorList>
<person name="Nordenskjold A."/>
<person name="Magnus O."/>
<person name="Aagenaes O."/>
<person name="Knudtzon J."/>
</authorList>
<dbReference type="PubMed" id="9843052"/>
<dbReference type="DOI" id="10.1002/(SICI)1096-8628(19981116)80:3&lt;269::AID-AJMG18>3.3.CO;2-K"/>
</citation>
<scope>VARIANT PPSH THR-228</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1998" name="J. Clin. Endocrinol. Metab." volume="83" first="3236" last="3238">
<title>Molecular characterization of 5-alpha-reductase type 2 deficiency and fertility in a Swedish family.</title>
<authorList>
<person name="Nordenskjold A."/>
<person name="Ivarsson S.-A."/>
</authorList>
<dbReference type="PubMed" id="9745434"/>
<dbReference type="DOI" id="10.1210/jcem.83.9.5125"/>
</citation>
<scope>VARIANTS PPSH SER-196 AND ARG-231</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1999" name="Lancet" volume="354" first="975" last="978">
<title>Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA.</title>
<authorList>
<person name="Makridakis N.M."/>
<person name="Ross R.K."/>
<person name="Pike M.C."/>
<person name="Crocitto L.E."/>
<person name="Kolonel L.N."/>
<person name="Pearce C.L."/>
<person name="Henderson B.E."/>
<person name="Reichardt J.K.V."/>
</authorList>
<dbReference type="PubMed" id="10501358"/>
<dbReference type="DOI" id="10.1016/S0140-6736(98)11282-5"/>
</citation>
<scope>VARIANT THR-49</scope>
<scope>POLYMORPHISM</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2000" name="Clin. Endocrinol. (Oxf.)" volume="52" first="383" last="387">
<title>Identification of missense mutations in the SRD5A2 gene from patients with steroid 5alpha-reductase 2 deficiency.</title>
<authorList>
<person name="Vilchis F."/>
<person name="Mendez J.P."/>
<person name="Canto P."/>
<person name="Lieberman E."/>
<person name="Chavez B."/>
</authorList>
<dbReference type="PubMed" id="10718838"/>
<dbReference type="DOI" id="10.1046/j.1365-2265.2000.00941.x"/>
</citation>
<scope>VARIANTS PPSH ASP-85; ASP-115; ARG-212; TYR-245 AND GLN-246</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2000" name="J. Clin. Endocrinol. Metab." volume="85" first="3147" last="3150">
<title>Uniparental disomy in steroid 5-alpha-reductase 2 deficiency.</title>
<authorList>
<person name="Chavez B."/>
<person name="Valdez E."/>
<person name="Vilchis F."/>
</authorList>
<dbReference type="PubMed" id="10999800"/>
<dbReference type="DOI" id="10.1210/jcem.85.9.6786"/>
</citation>
<scope>VARIANTS PPSH ASP-197 AND ARG-212</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2000" name="Pharmacogenetics" volume="10" first="407" last="413">
<title>Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II.</title>
<authorList>
<person name="Makridakis N.M."/>
<person name="di Salle E."/>
<person name="Reichardt J.K."/>
</authorList>
<dbReference type="PubMed" id="10898110"/>
<dbReference type="DOI" id="10.1097/00008571-200007000-00004"/>
</citation>
<scope>VARIANTS ARG-5; LEU-30; ARG-48; THR-49; THR-51; LEU-89; MET-187; LEU-194; GLN-227 AND LEU-234</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2002" name="Cancer Epidemiol. Biomarkers Prev." volume="11" first="417" last="418">
<title>Steroid 5-alpha reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population study.</title>
<authorList>
<person name="Pearce C.L."/>
<person name="Makridakis N.M."/>
<person name="Ross R.K."/>
<person name="Pike M.C."/>
<person name="Kolonel L.N."/>
<person name="Henderson B.E."/>
<person name="Reichardt J.K.V."/>
</authorList>
<dbReference type="PubMed" id="11927504"/>
</citation>
<scope>VARIANT LEU-89</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2003" name="J. Clin. Endocrinol. Metab." volume="88" first="3431" last="3436">
<title>Micropenis and the 5alpha-reductase-2 (SRD5A2) gene: mutation and V89L polymorphism analysis in 81 Japanese patients.</title>
<authorList>
<person name="Sasaki G."/>
<person name="Ogata T."/>
<person name="Ishii T."/>
<person name="Kosaki K."/>
<person name="Sato S."/>
<person name="Homma K."/>
<person name="Takahashi T."/>
<person name="Hasegawa T."/>
<person name="Matsuo N."/>
</authorList>
<dbReference type="PubMed" id="12843198"/>
<dbReference type="DOI" id="10.1210/jc.2002-021415"/>
</citation>
<scope>VARIANT MICROPENIS GLN-227</scope>
<scope>VARIANT LEU-89</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2004" name="Eur. J. Hum. Genet." volume="12" first="321" last="332">
<title>Comprehensive evaluation of the association between prostate cancer and genotypes/haplotypes in CYP17A1, CYP3A4, and SRD5A2.</title>
<authorList>
<person name="Loukola A."/>
<person name="Chadha M."/>
<person name="Penn S.G."/>
<person name="Rank D."/>
<person name="Conti D.V."/>
<person name="Thompson D."/>
<person name="Cicek M."/>
<person name="Love B."/>
<person name="Bivolarevic V."/>
<person name="Yang Q."/>
<person name="Jiang Y."/>
<person name="Hanzel D.K."/>
<person name="Dains K."/>
<person name="Paris P.L."/>
<person name="Casey G."/>
<person name="Witte J.S."/>
</authorList>
<dbReference type="PubMed" id="14560315"/>
<dbReference type="DOI" id="10.1038/sj.ejhg.5201101"/>
</citation>
<scope>VARIANT THR-49</scope>
<scope>LACK OF ASSOCIATION WITH PROSTATE CANCER</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2004" name="Horm. Res." volume="62" first="259" last="264">
<title>Clinical, biochemical and morphologic diagnostic markers in an infant male pseudohermaphrodite patient with compound heterozygous mutations (G115D/R246W) in SRD5A2 gene.</title>
<authorList>
<person name="Fernandez-Cancio M."/>
<person name="Rodo J."/>
<person name="Andaluz P."/>
<person name="Martinez de Osaba M.J."/>
<person name="Rodriguez-Hierro F."/>
<person name="Esteban C."/>
<person name="Carrascosa A."/>
<person name="Audi L."/>
</authorList>
<dbReference type="PubMed" id="15528927"/>
<dbReference type="DOI" id="10.1159/000081893"/>
</citation>
<scope>VARIANTS PPSH ASP-115 AND TRP-246</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2005" name="Clin. Endocrinol. (Oxf.)" volume="63" first="375" last="380">
<title>SRD5A2 gene analysis in an Italian population of under-masculinized 46,XY subjects.</title>
<authorList>
<person name="Nicoletti A."/>
<person name="Baldazzi L."/>
<person name="Balsamo A."/>
<person name="Barp L."/>
<person name="Pirazzoli P."/>
<person name="Gennari M."/>
<person name="Radetti G."/>
<person name="Cacciari E."/>
<person name="Cicognani A."/>
</authorList>
<dbReference type="PubMed" id="16181229"/>
<dbReference type="DOI" id="10.1111/j.1365-2265.2005.02348.x"/>
</citation>
<scope>VARIANTS PPSH TRP-145; LEU-181; SER-196; PHE-235 AND GLN-246</scope>
<scope>VARIANTS THR-49 AND LEU-89</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2005" name="J. Mol. Med." volume="83" first="569" last="576">
<title>New mutations, hotspots, and founder effects in Brazilian patients with steroid 5alpha-reductase deficiency type 2.</title>
<authorList>
<person name="Hackel C."/>
<person name="Oliveira L.E."/>
<person name="Ferraz L.F."/>
<person name="Tonini M.M."/>
<person name="Silva D.N."/>
<person name="Toralles M.B."/>
<person name="Stuchi-Perez E.G."/>
<person name="Guerra-Junior G."/>
</authorList>
<dbReference type="PubMed" id="15770495"/>
<dbReference type="DOI" id="10.1007/s00109-005-0651-7"/>
</citation>
<scope>VARIANTS PPSH ARG-126; ARG-158; SER-183; SER-196; ASP-207 AND TRP-246</scope>
<scope>VARIANTS THR-49 AND LEU-89</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2005" name="Urology" volume="66" first="407" last="410">
<title>A novel missense mutation of 5-alpha reductase type 2 gene (SRD5A2) leads to severe male pseudohermaphroditism in a Turkish family.</title>
<authorList>
<person name="Bahceci M."/>
<person name="Ersay A.R."/>
<person name="Tuzcu A."/>
<person name="Hiort O."/>
<person name="Richter-Unruh A."/>
<person name="Gokalp D."/>
</authorList>
<dbReference type="PubMed" id="16098368"/>
<dbReference type="DOI" id="10.1016/j.urology.2005.02.021"/>
</citation>
<scope>VARIANT PPSH ARG-123</scope>
</reference>
<comment type="function">
<text evidence="4">Converts testosterone (T) into 5-alpha-dihydrotestosterone (DHT) and progesterone or corticosterone into their corresponding 5-alpha-3-oxosteroids. It plays a central role in sexual differentiation and androgen physiology.</text>
</comment>
<comment type="catalytic activity">
<text evidence="4">A 3-oxo-5-alpha-steroid + NADP(+) = a 3-oxo-Delta(4)-steroid + NADPH.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="4">0.9 uM for testosterone (at pH 6.0)</KM>
<KM evidence="4">8 uM for NADPH (at pH 6.0)</KM>
<Vmax evidence="4">1.9 nmol/min/mg enzyme with testosterone as substrate with NADPH as cofactor (at pH 6.0)</Vmax>
</kinetics>
<phDependence>
<text>Optimally active at acidic pHs.</text>
</phDependence>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Microsome membrane</location>
<topology>Multi-pass membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="23">Endoplasmic reticulum membrane</location>
<topology evidence="23">Multi-pass membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text>Expressed in high levels in the prostate and many other androgen-sensitive tissues.</text>
</comment>
<comment type="polymorphism">
<text evidence="2">Individuals with Thr-49 have an increased risk of prostate cancer (PubMed:10501358). The enzyme with Thr-49 has a higher in vitro V(max) than the Ala-49 enzyme (PubMed:10501358).</text>
</comment>
<comment type="disease" evidence="3 5 9 11 12 13 14 15 16 17 18 19 20">
<disease id="DI-02230">
<name>Pseudovaginal perineoscrotal hypospadias</name>
<acronym>PPSH</acronym>
<description>A form of male pseudohermaphroditism in which 46,XY males show ambiguous genitalia at birth, including perineal hypospadias and a blind perineal pouch, and develop masculinization at puberty. The name of the disorder stems from the finding of a blind-ending perineal opening resembling a vagina and a severely hypospadiac penis with the urethra opening onto the perineum.</description>
<dbReference type="MIM" id="264600"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="23">Belongs to the steroid 5-alpha reductase family.</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/srd5a2/"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/5_alpha_reductase"/>
<text>5-alpha reductase entry</text>
</comment>
<dbReference type="EC" id="1.3.1.22" evidence="4"/>
<dbReference type="EMBL" id="M74047">
<property type="protein sequence ID" value="AAA60586.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB047857">
<property type="protein sequence ID" value="BAB40419.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EF560740">
<property type="protein sequence ID" value="ABQ59050.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY884245">
<property type="protein sequence ID" value="AAW56942.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK316597">
<property type="protein sequence ID" value="BAG38184.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471053">
<property type="protein sequence ID" value="EAX00478.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC112252">
<property type="protein sequence ID" value="AAI12253.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC113641">
<property type="protein sequence ID" value="AAI13642.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L03843">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS74503.1"/>
<dbReference type="PIR" id="A49169">
<property type="entry name" value="A49169"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000339.2">
<property type="nucleotide sequence ID" value="NM_000348.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.458345"/>
<dbReference type="ProteinModelPortal" id="P31213"/>
<dbReference type="BioGrid" id="112594">
<property type="interactions" value="1"/>
</dbReference>
<dbReference type="IntAct" id="P31213">
<property type="interactions" value="1"/>
</dbReference>
<dbReference type="BindingDB" id="P31213"/>
<dbReference type="ChEMBL" id="CHEMBL1856"/>
<dbReference type="DrugBank" id="DB00548">
<property type="generic name" value="Azelaic Acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB01126">
<property type="generic name" value="Dutasteride"/>
</dbReference>
<dbReference type="DrugBank" id="DB01216">
<property type="generic name" value="Finasteride"/>
</dbReference>
<dbReference type="DrugBank" id="DB00421">
<property type="generic name" value="Spironolactone"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2633"/>
<dbReference type="iPTMnet" id="P31213"/>
<dbReference type="PhosphoSitePlus" id="P31213"/>
<dbReference type="BioMuta" id="SRD5A2"/>
<dbReference type="DMDM" id="401056"/>
<dbReference type="PeptideAtlas" id="P31213"/>
<dbReference type="PRIDE" id="P31213"/>
<dbReference type="DNASU" id="6716"/>
<dbReference type="Ensembl" id="ENST00000622030">
<property type="protein sequence ID" value="ENSP00000477587"/>
<property type="gene ID" value="ENSG00000277893"/>
</dbReference>
<dbReference type="GeneID" id="6716"/>
<dbReference type="KEGG" id="hsa:6716"/>
<dbReference type="UCSC" id="uc032nip.2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6716"/>
<dbReference type="DisGeNET" id="6716"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000277893.1"/>
<dbReference type="GeneCards" id="SRD5A2"/>
<dbReference type="H-InvDB" id="HIX0030017"/>
<dbReference type="HGNC" id="HGNC:11285">
<property type="gene designation" value="SRD5A2"/>
</dbReference>
<dbReference type="MalaCards" id="SRD5A2"/>
<dbReference type="MIM" id="264600">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="607306">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P31213"/>
<dbReference type="Orphanet" id="753">
<property type="disease" value="46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency"/>
</dbReference>
<dbReference type="Orphanet" id="1331">
<property type="disease" value="Familial prostate cancer"/>
</dbReference>
<dbReference type="PharmGKB" id="PA36113"/>
<dbReference type="HOVERGEN" id="HBG003402"/>
<dbReference type="InParanoid" id="P31213"/>
<dbReference type="KO" id="K12344"/>
<dbReference type="OrthoDB" id="EOG091G0KU4"/>
<dbReference type="PhylomeDB" id="P31213"/>
<dbReference type="BioCyc" id="MetaCyc:HS00619-MONOMER"/>
<dbReference type="BRENDA" id="1.3.1.22">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="BRENDA" id="1.3.99.5">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-193048">
<property type="pathway name" value="Androgen biosynthesis"/>
</dbReference>
<dbReference type="ChiTaRS" id="SRD5A2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="SRD5A2"/>
<dbReference type="GenomeRNAi" id="6716"/>
<dbReference type="PRO" id="PR:P31213"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000277893"/>
<dbReference type="CleanEx" id="HS_SRD5A2"/>
<dbReference type="Genevisible" id="P31213">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0070852">
<property type="term" value="C:cell body fiber"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0043025">
<property type="term" value="C:neuronal cell body"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031090">
<property type="term" value="C:organelle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0003865">
<property type="term" value="F:3-oxo-5-alpha-steroid 4-dehydrogenase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0033218">
<property type="term" value="F:amide binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0047751">
<property type="term" value="F:cholestenone 5-alpha-reductase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0009917">
<property type="term" value="F:sterol 5-alpha reductase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030283">
<property type="term" value="F:testosterone dehydrogenase [NAD(P)] activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006702">
<property type="term" value="P:androgen biosynthetic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008209">
<property type="term" value="P:androgen metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018879">
<property type="term" value="P:biphenyl metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060348">
<property type="term" value="P:bone development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007267">
<property type="term" value="P:cell-cell signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018894">
<property type="term" value="P:dibenzo-p-dioxin metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030540">
<property type="term" value="P:female genitalia development"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0021766">
<property type="term" value="P:hippocampus development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0021854">
<property type="term" value="P:hypothalamus development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030539">
<property type="term" value="P:male genitalia development"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008584">
<property type="term" value="P:male gonad development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018963">
<property type="term" value="P:phthalate metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042448">
<property type="term" value="P:progesterone metabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032354">
<property type="term" value="P:response to follicle-stimulating hormone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031667">
<property type="term" value="P:response to nutrient levels"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043434">
<property type="term" value="P:response to peptide hormone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048545">
<property type="term" value="P:response to steroid hormone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033574">
<property type="term" value="P:response to testosterone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006706">
<property type="term" value="P:steroid catabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0061370">
<property type="term" value="P:testosterone biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR016636">
<property type="entry name" value="3-oxo-5-alpha-steroid_4-DH"/>
</dbReference>
<dbReference type="InterPro" id="IPR001104">
<property type="entry name" value="3-oxo-5_a-steroid_4-DH_C"/>
</dbReference>
<dbReference type="Pfam" id="PF02544">
<property type="entry name" value="Steroid_dh"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF015596">
<property type="entry name" value="5_alpha-SR2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50244">
<property type="entry name" value="S5A_REDUCTASE"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0492">Microsome</keyword>
<keyword id="KW-0521">NADP</keyword>
<keyword id="KW-0560">Oxidoreductase</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0657">Pseudohermaphroditism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0726">Sexual differentiation</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="chain" description="3-oxo-5-alpha-steroid 4-dehydrogenase 2" id="PRO_0000213676">
<location>
<begin position="1"/>
<end position="254"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="1">
<location>
<begin position="8"/>
<end position="28"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="1">
<location>
<begin position="72"/>
<end position="92"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="1">
<location>
<begin position="146"/>
<end position="166"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="1">
<location>
<begin position="206"/>
<end position="226"/>
</location>
</feature>
<feature type="sequence variant" description="No effect on affinity for testosterone; no effect on affinity for NADPH; no effect on Vmax." id="VAR_077546" evidence="4">
<original>C</original>
<variation>R</variation>
<location>
<position position="5"/>
</location>
</feature>
<feature type="sequence variant" description="Increased affinity for testosterone; increased affinity for NADPH; decreased Vmax." id="VAR_077547" evidence="4">
<original>P</original>
<variation>L</variation>
<location>
<position position="30"/>
</location>
</feature>
<feature type="sequence variant" description="Increased affinity for testosterone; increased affinity for NADPH; decreased Vmax." id="VAR_077548" evidence="4">
<original>P</original>
<variation>R</variation>
<location>
<position position="48"/>
</location>
</feature>
<feature type="sequence variant" description="Increased affinity for testosterone; no effect on affinity for NADPH; increased Vmax; no effect on affinity for testosterone when associated with L-89; no effect on affinity for NADPH when associated with L-89; increased Vmax when associated with L-89; dbSNP:rs9282858." id="VAR_013104" evidence="2 4 8 12 14 22">
<original>A</original>
<variation>T</variation>
<location>
<position position="49"/>
</location>
</feature>
<feature type="sequence variant" description="No effect on affinity for testosterone; increased affinity for NADPH; decreased Vmax." id="VAR_077549" evidence="4">
<original>A</original>
<variation>T</variation>
<location>
<position position="51"/>
</location>
</feature>
<feature type="sequence variant" description="In PPSH." id="VAR_013105" evidence="17">
<original>L</original>
<variation>Q</variation>
<location>
<position position="55"/>
</location>
</feature>
<feature type="sequence variant" description="In PPSH." id="VAR_013130" evidence="3">
<original>G</original>
<variation>D</variation>
<location>
<position position="85"/>
</location>
</feature>
<feature type="sequence variant" description="No effect on affinity for testosterone; no effect on affinity for NADPH; decreased Vmax; no effect on affinity for testosterone when associated with T-49; no effect on affinity for NADPH when associated with T-49; increased Vmax when associated with T-49; decreased affinity for testosterone when associated with M-187; increased affinity for NADPH when associated with M-187; decreased Vmax when associated with M-187; no effect on affinity for testosterone when associated with L-234; increased affinity for NADPH when associated with L-234; decreased Vmax when associated with L-234; dbSNP:rs523349." id="VAR_013131" evidence="4 6 7 10 12 14 21 22">
<original>V</original>
<variation>L</variation>
<location>
<position position="89"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28383048." id="VAR_022302" evidence="22">
<original>L</original>
<variation>V</variation>
<location>
<position position="113"/>
</location>
</feature>
<feature type="sequence variant" description="In PPSH." id="VAR_013106" evidence="3 11 16">
<original>G</original>
<variation>D</variation>
<location>
<position position="115"/>
</location>
</feature>
<feature type="sequence variant" description="In PPSH." id="VAR_025854" evidence="13">
<original>G</original>
<variation>R</variation>
<location>
<position position="123"/>
</location>
</feature>
<feature type="sequence variant" description="In PPSH." id="VAR_025855" evidence="12">
<original>Q</original>
<variation>R</variation>
<location>
<position position="126"/>
</location>
</feature>
<feature type="sequence variant" description="In PPSH." id="VAR_025851" evidence="14">
<original>R</original>
<variation>W</variation>
<location>
<position position="145"/>
</location>
</feature>
<feature type="sequence variant" description="In PPSH." id="VAR_013107" evidence="15">
<location>
<position position="157"/>
</location>
</feature>
<feature type="sequence variant" description="In PPSH." id="VAR_025856" evidence="12">
<original>G</original>
<variation>R</variation>
<location>
<position position="158"/>
</location>
</feature>
<feature type="sequence variant" description="In PPSH." id="VAR_025852" evidence="14">
<original>P</original>
<variation>L</variation>
<location>
<position position="181"/>
</location>
</feature>
<feature type="sequence variant" description="In PPSH." id="VAR_013108" evidence="12 16">
<original>G</original>
<variation>S</variation>
<location>
<position position="183"/>
</location>
</feature>
<feature type="sequence variant" description="No effect on affinity for testosterone; increased affinity for NADPH; decreased Vmax; decreased affinity for testosterone when associated with L-89; increased affinity for NADPH when associated with L-89; decreased Vmax when associated with L-89." id="VAR_077550" evidence="4">
<original>T</original>
<variation>M</variation>
<location>
<position position="187"/>
</location>
</feature>
<feature type="sequence variant" description="No effect on affinity for testosterone; increased affinity for NADPH; increased Vmax." id="VAR_077551" evidence="4">
<original>F</original>
<variation>L</variation>
<location>
<position position="194"/>
</location>
</feature>
<feature type="sequence variant" description="In PPSH." id="VAR_013109" evidence="12 14 19">
<original>G</original>
<variation>S</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="sequence variant" description="In PPSH." id="VAR_013110" evidence="5">
<original>E</original>
<variation>D</variation>
<location>
<position position="197"/>
</location>
</feature>
<feature type="sequence variant" description="In PPSH." id="VAR_013132" evidence="18">
<original>E</original>
<variation>K</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs9332961." id="VAR_059791">
<original>G</original>
<variation>S</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="sequence variant" description="In PPSH." id="VAR_025857" evidence="12">
<original>A</original>
<variation>D</variation>
<location>
<position position="207"/>
</location>
</feature>
<feature type="sequence variant" description="In PPSH." id="VAR_013111" evidence="3 5">
<original>P</original>
<variation>R</variation>
<location>
<position position="212"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs9332963." id="VAR_059792">
<original>L</original>
<variation>H</variation>
<location>
<position position="224"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs9332963." id="VAR_037585">
<original>L</original>
<variation>M</variation>
<location>
<position position="224"/>
</location>
</feature>
<feature type="sequence variant" description="In micropenis; increased affinity for testosterone; increased affinity for NADPH; decreased Vmax; dbSNP:rs9332964." id="VAR_037586" evidence="4 7">
<original>R</original>
<variation>Q</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence variant" description="In PPSH." id="VAR_013112" evidence="20">
<original>A</original>
<variation>T</variation>
<location>
<position position="228"/>
</location>
</feature>
<feature type="sequence variant" description="In PPSH." id="VAR_013113" evidence="19">
<original>H</original>
<variation>R</variation>
<location>
<position position="231"/>
</location>
</feature>
<feature type="sequence variant" description="Increased affinity for testosterone; increased affinity for NADPH; decreased Vmax; no effect on affinity for testosterone when associated with L-89; increased affinity for NADPH when associated with L-89; decreased Vmax when associated with L-89." id="VAR_077552" evidence="4">
<original>F</original>
<variation>L</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="sequence variant" description="In PPSH." id="VAR_025853" evidence="14">
<original>Y</original>
<variation>F</variation>
<location>
<position position="235"/>
</location>
</feature>
<feature type="sequence variant" description="In PPSH." id="VAR_013133" evidence="3">
<original>S</original>
<variation>Y</variation>
<location>
<position position="245"/>
</location>
</feature>
<feature type="sequence variant" description="In PPSH; dbSNP:rs9332967." id="VAR_013134" evidence="3 14">
<original>R</original>
<variation>Q</variation>
<location>
<position position="246"/>
</location>
</feature>
<feature type="sequence variant" description="In PPSH." id="VAR_005609" evidence="9 11 12 16">
<original>R</original>
<variation>W</variation>
<location>
<position position="246"/>
</location>
</feature>
<evidence key="1" type="ECO:0000255"/>
<evidence key="2" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10501358"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10718838"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10898110"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10999800"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11927504"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12843198"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14560315"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1522235"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15528927"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15770495"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16098368"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16181229"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7554313"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8626825"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8768837"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9208814"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9745434"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9843052"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="22" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="23" type="ECO:0000305"/>
<sequence length="254" mass="28393" checksum="E65A19C8600DED05" modified="1993-07-01" version="1">
MQVQCQQSPVLAGSATLVALGALALYVAKPSGYGKHTESLKPAATRLPARAAWFLQELPS
FAVPAGILARQPLSLFGPPGTVLLGLFCVHYFHRTFVYSLLNRGRPYPAILILRGTAFCT
GNGVLQGYYLIYCAEYPDGWYTDIRFSLGVFLFILGMGINIHSDYILRQLRKPGEISYRI
PQGGLFTYVSGANFLGEIIEWIGYALATWSLPALAFAFFSLCFLGLRAFHHHRFYLKMFE
DYPKSRKALIPFIF
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>